These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12517502)

  • 41. Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.
    Peeters M; Price TJ; Cervantes A; Sobrero AF; Ducreux M; Hotko Y; André T; Chan E; Lordick F; Punt CJ; Strickland AH; Wilson G; Ciuleanu TE; Roman L; Van Cutsem E; Tzekova V; Collins S; Oliner KS; Rong A; Gansert J
    J Clin Oncol; 2010 Nov; 28(31):4706-13. PubMed ID: 20921462
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Adjuvant therapy of colon carcinoma: results of two Intergroup Studies (INT-0035 and INT-0089), a study by the German Cancer Aid 17-1A Study Group and the IMPACT Study].
    Petrasch S; Schmiegel W
    Z Gastroenterol; 1997 Jan; 35(1):49-52. PubMed ID: 9123959
    [No Abstract]   [Full Text] [Related]  

  • 43. Radioimmunotherapy and colorectal cancer.
    Koppe MJ; Bleichrodt RP; Oyen WJ; Boerman OC
    Br J Surg; 2005 Mar; 92(3):264-76. PubMed ID: 15739250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Introduction. Critical role of anti-angiogenesis and VEGF inhibition in colorectal cancer.
    Díaz-Rubio E; Schmoll HJ
    Oncology; 2005; 69 Suppl 3():1-3. PubMed ID: 16301829
    [No Abstract]   [Full Text] [Related]  

  • 45. Hypomagnesemia is a reliable predictor for efficacy of anti-EGFR monoclonal antibody used in combination with first-line chemotherapy for metastatic colorectal cancer.
    Fujii H; Iihara H; Suzuki A; Kobayashi R; Matsuhashi N; Takahashi T; Yoshida K; Itoh Y
    Cancer Chemother Pharmacol; 2016 Jun; 77(6):1209-15. PubMed ID: 27106835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Colorectal cancer: current treatment options].
    Graeven U; Andre N; Schmiegel W
    Z Gastroenterol; 2004 Dec; 42(12):1399-407. PubMed ID: 15592965
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma.
    Venook AP
    Cancer; 2005 Jun; 103(12):2435-46. PubMed ID: 15880563
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.
    Chung KY; Shia J; Kemeny NE; Shah M; Schwartz GK; Tse A; Hamilton A; Pan D; Schrag D; Schwartz L; Klimstra DS; Fridman D; Kelsen DP; Saltz LB
    J Clin Oncol; 2005 Mar; 23(9):1803-10. PubMed ID: 15677699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study.
    Douillard JY; Siena S; Cassidy J; Tabernero J; Burkes R; Barugel M; Humblet Y; Bodoky G; Cunningham D; Jassem J; Rivera F; Kocákova I; Ruff P; Błasińska-Morawiec M; Šmakal M; Canon JL; Rother M; Oliner KS; Wolf M; Gansert J
    J Clin Oncol; 2010 Nov; 28(31):4697-705. PubMed ID: 20921465
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cetuximab.
    Graham J; Muhsin M; Kirkpatrick P
    Nat Rev Drug Discov; 2004 Jul; 3(7):549-50. PubMed ID: 15272498
    [No Abstract]   [Full Text] [Related]  

  • 51. Anti-EpCAM monoclonal antibody (MAb17-1A) based treatment combined with alpha-interferon, 5-fluorouracil and granulocyte-macrophage colony-stimulating factor in patients with metastatic colorectal carcinoma.
    Liljefors M; Ragnhammar P; Nilsson B; Ullenhag G; Mellstedt H; Frödin JE
    Int J Oncol; 2004 Sep; 25(3):703-11. PubMed ID: 15289873
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Some problems facing the molecular targeting therapy for colorectal cancer].
    Xu JM
    Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):321-3. PubMed ID: 19799077
    [No Abstract]   [Full Text] [Related]  

  • 53. Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche.
    Xu X; Chang W; Yuan J; Han X; Tan X; Ding Y; Luo Y; Cai H; Liu Y; Gao X; Liu Q; Yu Y; Du Y; Wang H; Ma L; Wang J; Chen K; Ding Y; Fu C; Cao G
    Oncotarget; 2016 Jan; 7(1):798-813. PubMed ID: 26556874
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression changes in epithelial cell adhesion molecule during colorectal cancer tumorigenesis.
    Chai XB; Song RF; Xu F
    Genet Mol Res; 2015 Jul; 14(3):7624-9. PubMed ID: 26214441
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of new agents in the treatment of colorectal cancer.
    Ruiz de Erenchun F
    Oncology; 2005; 68(2-3):162; author reply 162. PubMed ID: 16097096
    [No Abstract]   [Full Text] [Related]  

  • 56. EpCAM as a target in cancer therapy.
    Gires O; Bauerle PA
    J Clin Oncol; 2010 May; 28(15):e239-40; author reply e241-2. PubMed ID: 20385979
    [No Abstract]   [Full Text] [Related]  

  • 57. Adjuvant chemotherapy for stage II and III colorectal cancer.
    Benson AB
    Clin Adv Hematol Oncol; 2011 Aug; 9(8):616-8. PubMed ID: 22236990
    [No Abstract]   [Full Text] [Related]  

  • 58. Cetuximab in the first-line therapy of metastatic colorectal carcinoma: not so CRYSTAL clear.
    Windsor AC; Cohen R; Jiao LR; Stebbing J
    Future Oncol; 2008 Dec; 4(6):741-4. PubMed ID: 19086837
    [No Abstract]   [Full Text] [Related]  

  • 59. K-Ras mutations are changing practice in advanced colorectal cancer.
    McNeil C
    J Natl Cancer Inst; 2008 Dec; 100(23):1667-9. PubMed ID: 19033564
    [No Abstract]   [Full Text] [Related]  

  • 60. Challenges in the use of epidermal growth factor receptor inhibitors in colorectal cancer.
    Van Cutsem E
    Oncologist; 2006 Oct; 11(9):1010-7. PubMed ID: 17030643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.